Agenda

Friday, December 6, 2024 All times in Eastern Time
7:00 am	Registration & Breakfast
8:00 am	Welcome and Announcements Brian Griffin, MD
Session 1: Mitral Valve Disease - A Primer for an Ever Changing Landscape Moderators: Milind Desai, MD, MBA, and Samir Kapadia, MD
8:10 am	Guideline directed management of mitral valve disease: When, why and how to intervene Brian Griffin, MD
8:25 am	Gender differences in diagnosis and presentation of mitral disease Leslie Cho, MD
8:40 am	Imaging of the mitral valve for screening: the ABCs - Echo vs. TEE vs. Stress Echo Rhonda Miyasaka, MD
8:55 am	Role of advanced imaging (CT and MRI) in screening/workup of the mitral valve patient to the OR and the cath lab Serge Harb, MD
9:10 am	Case presentation L. Leonardo Rodriguez, MD
	9:15 am Imaging considerations during TEER and surgery Serge Harb, MD
	9:25 am Interventional cardiologist: TEER Amar Krishnaswamy, MD
	9:35 am Surgeon: Can I do a low risk MV repair and what I would do and why? Sternotomy versus Robotic Stephanie Mick, MD
	9:45 am PRIMARY and REPAIR Trials: Lessons learned and implications for patient trial design, endpoints and inclusion criteria Aubrey Galloway, MD
	10:00 am What happened to the patient, panel discussion and attendee Q&A All session faculty
10:15 am	Break
Session 2: Management of Tricuspid Valve Disease Moderators: Brian Griffin, MD, and Amar Krishnaswamy, MD
10:35 am	The natural history of tricuspid regurgitation Brian Griffin, MD
10:50 am	Tricuspid valve imaging: Considerations for assessment Serge Harb, MD
11:05 am	Case presentation L. Leonardo Rodriguez, MD
	11:10 am Cardiology: Work up of a patient with TR: What is the current data on risk stratification? Milind Desai, MD, MBA
	11:20 am Addressing the tricuspid valve during mitral valve surgery: Any benefit? Tarek Malas, MD
	11:30 am Interventionalist: Edge to edge TVR or tricuspid valve replacement Samir Kapadia, MD
	11:40 am The EP physician as a member of the TR heart team Thomas Callahan, IV, MD
	11:50 am What happened to the patient, panel discussion and attendee Q&A All session faculty
12:05 pm	Lunch
Session 3: Ventricular Arrhythmias and MR Moderators: Leslie Cho, MD, and Thomas Callahan, IV, MD
1:05 pm	Mitral regurgitation and ventricular arrhythmias – what is the data? Thomas Callahan, IV, MD
1:20 pm	Case presentation Milind Desai, MD, MBA
	1:25 pm Can I follow safely without intervention and how should I investigate this patient? Risk stratification: Which patient warrants early primary prevention Thomas Callahan, IV, MD
	1:35 pm Imaging predictors of ventricular arrhythmias and SCD Milind Desai, MD, MBA
	1:45 pm What happened to the patient, panel discussion and attendee Q&A All session faculty
Session 4: Atrial Arrhythmias and MR Moderators: Stephanie Mick, MD, and L. Leonardo Rodriguez, MD
2:00 pm	Defining atrial functional MR: Pathophysiology L. Leonardo Rodriguez, MD
2:15 pm	Atrial FMR: Role for EP intervention, antiarrhythmics, ablation, Watchman, leadless pacemakers Thomas Callahan, IV, MD
2:30 pm	Case presentation Serge Harb, MD
	2:35 pm Imaging Assessment Rhonda Miyasaka, MD
	2:45 pm Surgical perspective: The role of surgery in atrial functional MR Stephanie Mick, MD
	2:55 pm Interventional cardiologist perspective Samir Kapadia, MD
	3:05 pm What happened to the patient, panel discussion and attendee Q&A
3:20 pm	Break
Session 5: TEER: State of the Art Moderators: Samir Kapadia, MD, and Rhonda Miyasaka, MD
3:35 pm	Device selection and outcomes for MR: Mitraclip and Pascal Amar Krishnaswamy, MD
3:50 pm	Case presentation Rhonda Miyasaka, MD
	3:55 pm Cardiologist: How I assess the patient and the key role of imaging Serge Harb, MD
	4:05 pm Interventionalist: Tips and tricks for planning and execution - How to reduce failures and maximize durability Samir Kapadia, MD
	4:15 pm Surgical Perspective Aubrey Galloway, MD
	4:25 pm What happened to the patient, panel discussion and attendee Q&A All session faculty
4:40 pm	Adjourn Day 1

Back to top

Saturday, December 7, 2024
Session 6: Ischemic MR Moderators: Milind Desai, MD, MBA, and Brian Griffin, MD
7:15 am	Registration & Breakfast
8:00 am	Challenges and limitations of current management and technology Brian Griffin, MD
8:15 am	Case presentation L. Leonardo Rodriguez, MD
	8:20 am Clinical cardiologist: What is guideline-directed medical therapy in ischemic MR and is it enough? Brian Griffin, MD
	8:30 am EP Cardiologist: How to maximize roles of CRT and ICD in secondary MR to prevent or delay intervention Thomas Callahan, IV, MD
	8:40 am Debate - Surgery for severe ischemic MR: Repair or replace? Tarek Malas, MD
	8:45 am Debate - Interventional management provides superior outcomes Samir Kapadia, MD
	8:50 am Surgical rebuttal
	8:53 am Interventional rebuttal
	8:56 am What happened to the patient, panel discussion and attendee Q&A All session faculty
9:10 am	Break
Session 7: Torrential Tricuspid Regurgitation Moderators: Serge Harb, MD, and L. Leonardo Rodriguez, MD
9:30 am	The current and future of transcatheter tricuspid intervention: Lessons from the trials - EVOQUE, Tricvalve, and TriClip Amar Krishnaswamy, MD
9:45 am	Case presentation L. Leonardo Rodriguez, MD
	9:50 am Patient selection in TR: Predictors of success from multimodality imaging Rhonda Miyasaka, MD
	10:00 am Intervention: Repair versus replacement Samir Kapadia, MD
	10:10 am PPM/ICD options in patients follow TR Interventions Thomas Callahan, IV, MD
	10:20 am What happened to the patient, panel discussion and attendee Q&A All session faculty
Session 8: HOCM: When and How to Address the Mitral Valve Moderators: Milind Desai, MD, MBA, and Samir Kapadia, MD
10:35 am	Case presentation Milind Desai, MD, MBA
	10:40 am Interventional strategies in HOCM Samir Kapadia, MD
	10:50 am Medical management - What’s new? Milind Desai, MD, MBA
	11:00 am Surgeon: Myectomy +/- Mitral Tarek Malas, MD
	11:10 am What happened to the patient, panel discussion and attendee Q&A All session faculty
Session 9: Management Approaches to Complex Scenarios - Case Based Moderators: Brian Griffin, MD, and Tarek Malas, MD
11:25 am	Critical care management in the setting of acute decompensated valvular heart disease Leslie Cho, MD
11:35 am	Severe mitral regurgitation after TEER – When and how to intervene in persistent or recurrent symptoms after intervention - what next? Amar Krishnaswamy, MD
11:45 am	Mitral valve dysfunction with underlying calcification including MAC Tarek Malas, MD
11:55 am	Management of combined mitral valve and tricuspid disease Stephanie Mick, MD
12:05 pm	Pre-existing CIED lead management in tricuspid valve intervention Thomas Callahan, IV, MD
12:15 pm	Panel discussion and attendee Q&A All session faculty
12:30 pm	Adjourn

Back to top